These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29913490)

  • 1. Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations.
    Maselli DJ; Peters JI
    Ann Intern Med; 2018 Jun; 168(12):JC65. PubMed ID: 29913490
    [No Abstract]   [Full Text] [Related]  

  • 2. Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations.
    McKeever T; Mortimer K; Wilson A; Walker S; Brightling C; Skeggs A; Pavord I; Price D; Duley L; Thomas M; Bradshaw L; Higgins B; Haydock R; Mitchell E; Devereux G; Harrison T
    N Engl J Med; 2018 Mar; 378(10):902-910. PubMed ID: 29504499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quintupling or quadrupling inhaled glucocorticoids to prevent asthma exacerbations?
    Roberts G
    Clin Exp Allergy; 2018 Apr; 48(4):352-353. PubMed ID: 29577486
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid therapy for asthma in children.
    Spahn JD; Szefler SJ
    Curr Opin Pediatr; 2007 Jun; 19(3):300-5. PubMed ID: 17505190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escalating Inhaled Glucocorticoids to Prevent Asthma Exacerbations.
    Bardin PG
    N Engl J Med; 2018 Mar; 378(10):950-952. PubMed ID: 29504500
    [No Abstract]   [Full Text] [Related]  

  • 6. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Oborne J; Mortimer K; Hubbard RB; Tattersfield AE; Harrison TW
    Am J Respir Crit Care Med; 2009 Oct; 180(7):598-602. PubMed ID: 19590019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nongenomic effects of glucocorticoids, an important mechanism of inhaled glucocorticoids action in asthma].
    Grzanka A; Jarzab J
    Pneumonol Alergol Pol; 2009; 77(5):453-9. PubMed ID: 19890825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence.
    Ducharme FM
    BMJ; 2002 Jun; 324(7353):1545. PubMed ID: 12089089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled glucocorticoids in children: A favourable therapeutic index.
    Simons FE
    Can Respir J; 1999; 6(2):175-8. PubMed ID: 10322100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
    Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
    Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attained adult height after childhood asthma: effect of glucocorticoid therapy.
    Silverstein MD; Yunginger JW; Reed CE; Petterson T; Zimmerman D; Li JT; O'Fallon WM
    J Allergy Clin Immunol; 1997 Apr; 99(4):466-74. PubMed ID: 9111490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.
    Levy ML; Stevenson C; Maslen T
    Thorax; 1996 Nov; 51(11):1087-92. PubMed ID: 8958890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
    Ducharme FM; Hicks GC
    Cochrane Database Syst Rev; 2000; (3):CD002314. PubMed ID: 10908555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D; Salvio F; Hicks G
    Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months.
    Maselli DJ; Peters JI
    Ann Intern Med; 2017 Oct; 167(8):JC43. PubMed ID: 29049762
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of inhaled glucocorticoid treatment on placental 11beta-hydroxysteroid dehydrogenase type 2 activity and neonatal birthweight in pregnancies complicated by asthma.
    Clifton VL; Rennie N; Murphy VE
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):136-40. PubMed ID: 16638036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhaled corticotherapy in asthma: when should it be started and how to stop?].
    Aubier M
    Rev Pneumol Clin; 1996; 52(2):145-9. PubMed ID: 8761645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher dose inhaled steroids in childhood asthma. Why isn't titration advocated more often in delivery of inhaled drugs?
    Cates C
    BMJ; 2001 Jun; 322(7301):1546. PubMed ID: 11439999
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma.
    Phillips K; Oborne J; Harrison TW; Tattersfield AE
    Thorax; 2004 Jan; 59(1):21-5. PubMed ID: 14694241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.